Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.

× No keyword cloud information.

11 in total

1. Rhabdomyolysis caused by an interaction of simvastatin and fusidic acid.

Authors: Roselle Herring; Gordon Caldwell; Stuart Wade
Journal: BMJ Case Rep Date: 2009-09-20

2. [Information regarding adverse drug effects and treatment indications ("package inserts") exemplified by cervistatin (Lipobay)].

Authors: Robert N Braun; Max J Halhuber; Gerhart Hitzenberger
Journal: Wien Med Wochenschr Date: 2003

Review 3. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors: David Williams; John Feely
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

4. Rhabdomyolysis secondary to interaction between atorvastatin and fusidic acid.

Authors: Nabeel Tahir Muhammad Saeed; Mohammad Azam
Journal: BMJ Case Rep Date: 2009-09-15

Review 5. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.

Authors: H S Malhotra; K L Goa
Journal: Drugs Date: 2001 Impact factor: 9.546

6. Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.

Authors: Anshul Gupta; Jennifer J Harris; Jianrong Lin; James P Bulgarelli; Bruce K Birmingham; Scott W Grimm
Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191

Review 7. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.

Authors: Thomas Deljehier; Antoine Pariente; Ghada Miremont-Salamé; Françoise Haramburu; Linh Nguyen; Sébastien Rubin; Claire Rigothier; Hélène Théophile
Journal: Br J Clin Pharmacol Date: 2018-02-26 Impact factor: 4.335

Review 8. Clinical pharmacokinetics of atorvastatin.

Authors: Hans Lennernäs
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

Review 9. Hepatotoxicity of antibacterials: Pathomechanisms and clinical.

Authors: J M Leitner; W Graninger; F Thalhammer
Journal: Infection Date: 2010-01-27 Impact factor: 3.553

10. Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination.

Authors: Anirban Nandy; Shahin Gaïni
Journal: Case Rep Med Date: 2016-12-27